Chong Kun Dang Reports Q3 Operating Profit of 20.5 Billion Won, Down 18.7% Year-on-Year

Chong Kun Dang's third-quarter operating profit fell 18.7% year-on-year to 20.5 billion won, signaling ongoing margin pressures in South Korea's pharmaceutical sector.